Data Foundry

Drug recalls 2021

1% Lidocaine HCl Injection — Class I drug recall D-0627-2021

Terminated recall by PFIZER, INC, reported 2021-06-09, distributed nationwide. Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contai

Recall numberD-0627-2021
Product typeDrug
ClassificationClass I
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmPFIZER, INC, Lake Forest, IL, United States
Recall initiated2021-05-03
Classified2021-06-10
Reported by FDA2021-06-09
Terminated2023-04-04
DistributedNationwide (US)
Quantity139,050 vials
Reason classeslabeling
NDC00409-4279-02, 00409-4279-16
Lot numbersEG8933
Expiration dates2022-08-01

Product

1% Lidocaine HCl Injection, USP, 300 mg/30 mL (10 mg/mL), 30 mL Single-dose vial (NDC 0409-4279-16), packaged in 25 vials per tray (NDC 0409-4279-02), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA.

Reason for recall

Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0627-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-05. Not affiliated with or endorsed by FDA. Not medical or legal advice.